Files in this item
Bedaquiline: what might the future hold?
Item metadata
dc.contributor.author | Shaw, Emily S | |
dc.contributor.author | Stoker, Neil G | |
dc.contributor.author | Potter, Jessica L | |
dc.contributor.author | Claassen, Helgard | |
dc.contributor.author | Leslie, Alasdair | |
dc.contributor.author | Tweed, Conor D | |
dc.contributor.author | Chiang, Chen-Yuan | |
dc.contributor.author | Conradie, Francesca | |
dc.contributor.author | Esmail, Hanif | |
dc.contributor.author | Lange, Christoph | |
dc.contributor.author | Pinto, Lancelot | |
dc.contributor.author | Rucsineanu, Oxana | |
dc.contributor.author | Sloan, Derek J | |
dc.contributor.author | Theron, Grant | |
dc.contributor.author | Tisile, Phumeza | |
dc.contributor.author | Voo, Teck Chuan | |
dc.contributor.author | Warren, Robin M | |
dc.contributor.author | Lebina, Limakatso | |
dc.contributor.author | Lipman, Marc | |
dc.date.accessioned | 2024-08-12T16:30:14Z | |
dc.date.available | 2024-08-12T16:30:14Z | |
dc.date.issued | 2024-07-27 | |
dc.identifier | 306413951 | |
dc.identifier | cbb638f1-1666-414d-8d91-965ef3b5a2fe | |
dc.identifier | 39074472 | |
dc.identifier | 85199699607 | |
dc.identifier.citation | Shaw , E S , Stoker , N G , Potter , J L , Claassen , H , Leslie , A , Tweed , C D , Chiang , C-Y , Conradie , F , Esmail , H , Lange , C , Pinto , L , Rucsineanu , O , Sloan , D J , Theron , G , Tisile , P , Voo , T C , Warren , R M , Lebina , L & Lipman , M 2024 , ' Bedaquiline: what might the future hold? ' , The Lancet Microbe , vol. In Press , 100909 . https://doi.org/10.1016/S2666-5247(24)00149-6 | en |
dc.identifier.issn | 2666-5247 | |
dc.identifier.other | Jisc: 2180802 | |
dc.identifier.other | pii: S2666-5247(24)00149-6 | |
dc.identifier.uri | https://hdl.handle.net/10023/30380 | |
dc.description | Funding: We would like to acknowledge the following who contributed towards publication costs: (1) Africa Health Research Institute supported by Wellcome (Grant number Wellcome Strategic Core award: 227167/A/23/Z). (2) CL was supported by the German Center of Infection Research (DZIF) under agreement TTU-TB 02.709. (3) CYC was supported by Wan Fang Hospital, Taipei Medical University. (4) DJS was supported by University of St Andrews. (5) LP was supported by PD Hinduja Hospital and Medical Research Centre, Mumbai. (6) ML was supported by The Royal Free Charity. | en |
dc.description.abstract | Tuberculosis drug development has stagnated for decades, so the recent availability of bedaquiline is welcome. Bedaquiline-containing regimens, now the first-line therapy recommended by WHO, have transformed the treatment of drug-resistant tuberculosis, offering safer and more effective oral treatment options. However, key obstacles need to be overcome to ensure global access and prevent the rapid development of resistance against this promising class of drugs. In this Personal View, building on an international workshop held in 2023, we evaluate the current evidence and suggest possible ways forward, recognising the tension between increasing use and slowing the rise of resistance. We also discuss problems in accessing bedaquiline-containing regimens, the potential widening of their use beyond drug-resistant tuberculosis, and lessons for utilising new drugs as they are developed. | |
dc.format.extent | 8 | |
dc.format.extent | 238200 | |
dc.language.iso | eng | |
dc.relation.ispartof | The Lancet Microbe | en |
dc.subject | RA0421 Public health. Hygiene. Preventive Medicine | en |
dc.subject | T-NDAS | en |
dc.subject | SDG 3 - Good Health and Well-being | en |
dc.subject.lcc | RA0421 | en |
dc.title | Bedaquiline: what might the future hold? | en |
dc.type | Journal article | en |
dc.contributor.institution | University of St Andrews. School of Medicine | en |
dc.contributor.institution | University of St Andrews. Infection and Global Health Division | en |
dc.identifier.doi | 10.1016/S2666-5247(24)00149-6 | |
dc.description.status | Peer reviewed | en |
This item appears in the following Collection(s)
Items in the St Andrews Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.